Rep. April McClain Delaney Sells Shares of STERIS plc (NYSE:STE)

Key Points

• Rep. April McClain Delaney sold $100,001–$250,000 of STERIS shares on August 25, according to a September 9 disclosure. She also sold holdings in several other companies, including Wabtec, Viking, Trimble and TransDigm.
• STERIS reported quarterly adjusted earnings of $2.59 per share, beating estimates by $0.10, while revenue rose 7.3% year over year to $1.49 billion. The company raised its quarterly dividend from $0.63 to $0.69 per share, equivalent to a 1.3% annual yield.
• Analysts maintain a generally positive view, with three Buy ratings and one Hold rating and a consensus price target of $271.33. Institutional investors own approximately 94.69% of STERIS shares.

Representative April McClain Delaney (Democratic-Maryland) recently sold shares of STERIS plc NYSE: STE. In a filing disclosed on September 09th, the Representative disclosed that they had sold between $100,001 and $250,000 in STERIS stock on August 25th.

Representative April McClain Delaney also recently made the following trade(s):

• Sold $100,001 - $250,000 in shares of Wabtec NYSE: WAB on 8/25/2026.
• Sold $100,001 - $250,000 in shares of Viking NYSE: VIK on 8/25/2026.
• Sold $100,001 - $250,000 in shares of Trimble NASDAQ: TRMB on 8/25/2026.
• Sold $100,001 - $250,000 in shares of Transdigm Group NYSE: TDG on 8/25/2026.
• Sold $15,001 - $50,000 in shares of Tractor Supply NASDAQ: TSCO on 8/25/2026.
• Sold $15,001 - $50,000 in shares of Middleby NASDAQ: MIDD on 8/25/2026.
• Sold $15,001 - $50,000 in shares of Teledyne Technologies NYSE: TDY on 8/25/2026.
• Sold $100,001 - $250,000 in shares of Somnigroup International NYSE: SGI on 8/25/2026.
• Sold $100,001 - $250,000 in shares of Signet Jewelers NYSE: SIG on 8/25/2026.
• Sold $100,001 - $250,000 in shares of Paychex NASDAQ: PAYX on 8/25/2026.

STERIS Stock Performance

Shares of STERIS stock opened at $212.44 on Friday. The company has a market capitalization of $20.71 billion, a PE ratio of 25.97 and a beta of 0.91. The company has a 50-day simple moving average of $225.69 and a two-hundred day simple moving average of $221.22. STERIS plc has a one year low of $195.14 and a one year high of $269.44. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.35 and a current ratio of 1.91.

STERIS (NYSE:STE - Get Free Report) last posted its earnings results on Wednesday, August 5th. The medical equipment provider reported $2.59 EPS for the quarter, beating analysts' consensus estimates of $2.49 by $0.10. STERIS had a net margin of 13.34% and a return on equity of 14.34%. The company had revenue of $1.49 billion during the quarter, compared to analysts' expectations of $1.49 billion. During the same quarter in the prior year, the company posted $2.34 earnings per share. STERIS's revenue for the quarter was up 7.3% compared to the same quarter last year. STERIS has set its FY 2027 guidance at 11.000-11.300 EPS. Research analysts expect that STERIS plc will post 11.09 EPS for the current fiscal year.

STERIS Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Friday, September 4th will be given a dividend of $0.69 per share. The ex-dividend date of this dividend is Friday, September 4th. This is an increase from STERIS's previous quarterly dividend of $0.63. This represents a $2.76 dividend on an annualized basis and a yield of 1.3%. STERIS's dividend payout ratio is 33.74%.

Hedge Funds Weigh In On STERIS

A number of institutional investors have recently bought and sold shares of STE. California State Teachers Retirement System raised its position in shares of STERIS by 20,515.0% in the second quarter. California State Teachers Retirement System now owns 35,267,316 shares of the medical equipment provider's stock worth $7,426,239,000 after acquiring an additional 35,096,240 shares during the period. Norges Bank acquired a new stake in STERIS in the fourth quarter valued at approximately $320,298,000. AQR Capital Management LLC increased its position in shares of STERIS by 178.6% in the third quarter. AQR Capital Management LLC now owns 1,183,070 shares of the medical equipment provider's stock valued at $291,704,000 after buying an additional 758,423 shares in the last quarter. Boston Partners acquired a new position in shares of STERIS during the 3rd quarter worth approximately $158,982,000. Finally, Wellington Management Group LLP grew its stake in STERIS by 21.9% in the 2nd quarter. Wellington Management Group LLP now owns 3,502,897 shares of the medical equipment provider's stock valued at $737,605,000 after acquiring an additional 629,532 shares during the period. 94.69% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at STERIS

In other STERIS news, VP John Zangerle sold 1,419 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $209.28, for a total transaction of $296,968.32. Following the transaction, the vice president directly owned 35,259 shares of the company's stock, valued at $7,379,003.52. This trade represents a 3.87% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mohsen Sohi sold 4,058 shares of the business's stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $235.78, for a total transaction of $956,795.24. Following the sale, the director directly owned 24,305 shares of the company's stock, valued at $5,730,632.90. This represents a 14.31% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.12% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have commented on STE shares. Piper Sandler reiterated an "overweight" rating and issued a $275.00 price target (up from $270.00) on shares of STERIS in a research note on Friday, August 7th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of STERIS in a research report on Monday, August 24th. Wall Street Zen raised shares of STERIS from a "hold" rating to a "buy" rating in a research report on Sunday, August 9th. Finally, UBS Group lowered their price objective on shares of STERIS from $275.00 to $270.00 and set a "buy" rating for the company in a research note on Friday, August 7th. Three research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $271.33.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland's 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland's 6th Congressional District. She declared candidacy for the 2026 election. April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor's degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

STERIS Company Profile

STERIS plc NYSE: STE is a global provider of products and services designed to support infection prevention, sterilization, surgical procedures and other critical healthcare and life sciences activities. The company serves hospitals, ambulatory surgery centers, dental practices, pharmaceutical and biotechnology manufacturers, medical device companies, and research organizations.

Its offerings include sterilizers, washers, surgical tables and lights, operating-room equipment, endoscopy products, infection-prevention consumables, and related maintenance and technical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.